Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |